BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao LF, Sun WS, Ma CH, Liu SX, Wang XY, Zhang LN, Cao YL, Zhu FL, Liu YG. Establishment of mice model with human viral hepatitis B. World J Gastroenterol 2004; 10(6): 841-846 [PMID: 15040029 DOI: 10.3748/wjg.v10.i6.841]
URL: https://www.wjgnet.com/1948-5182/full/v10/i6/841.htm
Number Citing Articles
1
Hongmin Zhang, Hong Li, Yixuan Yang, Sanglin Li, Hong Ren, Dazhi Zhang, Huaidong Hu. Differential Regulation of Host Genes Including Hepatic Fatty Acid Synthase in HBV-Transgenic MiceJournal of Proteome Research 2013; 12(6): 2967 doi: 10.1021/pr400247f
2
Zhongmin Zhou, Cong Li, Zexi Tan, Guoliang Sun, Bo Peng, Tengfei Ren, Jiabei He, Yixue Wang, Yinyan Sun, Fengchao Wang, Wenhui Li. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virusAntiviral Research 2023; 216: 105642 doi: 10.1016/j.antiviral.2023.105642
3
Jianming Hu, You-Yu Lin, Pei-Jer Chen, Koichi Watashi, Takaji Wakita. Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug DevelopmentGastroenterology 2019; 156(2): 338 doi: 10.1053/j.gastro.2018.06.093
4
Wenqian Zhang, Jiao Zhang, Lianying Zhao, Jie Shao, Jian Cui, Chun Guo, Faliang Zhu, Youhai H. Chen, Suxia Liu. TIPE2 protein negatively regulates HBV-specific CD8+ T lymphocyte functions in humansMolecular Immunology 2015; 64(1): 204 doi: 10.1016/j.molimm.2014.11.019
5
S Zhen, L Hua, Y-H Liu, L-C Gao, J Fu, D-Y Wan, L-H Dong, H-F Song, X Gao. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virusGene Therapy 2015; 22(5): 404 doi: 10.1038/gt.2015.2
6
Chen Ding, Haiming Wei, Rui Sun, Jian Zhang, Zhigang Tian. Hepatocytes proteomic alteration and seroproteome analysis of HBV‐transgenic micePROTEOMICS 2009; 9(1): 87 doi: 10.1002/pmic.200701053
7
Zhongjun Dong, Jianhong Zhang, Rui Sun, Haiming Wei, Zhigang Tian. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic miceHepatology 2007; 45(6): 1400 doi: 10.1002/hep.21597
8
Xuemei Lu, Jie Wang, Xiaobao Jin, Jiayong Zhu. High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo BMC Biotechnology 2015; 15(1) doi: 10.1186/s12896-015-0177-1
9
Haoxiang Zhu, Yongmei Zhang, Hongyan Liu, Yijun Zhang, Yaoyue Kang, Richeng Mao, Feifei Yang, Dapeng Zhou, Jiming Zhang. Preserved Function of Circulating Invariant Natural Killer T Cells in Patients With Chronic Hepatitis B Virus InfectionMedicine 2015; 94(24): e961 doi: 10.1097/MD.0000000000000961
10
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X proteinCancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
11
Madhusudana Girija Sanal, Sarita Gupta, Rahul Saha, Nisha Vats, Shiv Kumar Sarin. Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular ReprogrammingCellular Reprogramming 2023; 25(5): 224 doi: 10.1089/cell.2023.0055